Leadership Team

The Leadership Team at Akashi Therapeutics is responsible for strategic decision-making and guiding the company's vision in the development of innovative therapies for Duchenne muscular dystrophy and other rare diseases. Comprising key executives—including the CEO and Chief Medical and Scientific Officers—this team collaborates to ensure scientific rigor, regulatory compliance, and alignment with the company's mission to deliver impactful treatments to underserved patient populations.